Market By Technology, Application, Component, End-user, And Geography | Forecast 2019-2027
A report by Triton Market Research states that the market for 3D cell culture in the Asia-Pacific would depict growth in revenue with a CAGR of 13.11% during the forecasted years between 2019 and 2027.
The countries studied in the Asia-Pacific market for 3D cell culture are:
• China
• Japan
• India
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC
Report scope can be customized per your requirements. Request For Customization
China is focusing increasingly on technological advancements to cater to the nation’s vast patient base. The increase in the number of elderly people and the high incidence rate of cancer have led to an increased demand for innovative drugs and therapies. China is a major country in the APAC region, owing to the several applications by the country for IP rights with respect to 3D cell culture. The World Gene Convention-2017 (WGC-2017), that addressed new developments in the fields of the gene, biotechnology, and life sciences, was conducted in Macao in 2017. Also, in the same year in April, the World Congress of Molecular & Cell Biology was held in the country. Such initiatives are expected to foster the development of China’s 3D cell culture market.
India is increasingly concentrating on R&D in the healthcare sector. Several contract research organizations are situated in the country, that carry out numerous projects for research in oncology, stem cells, and regenerative medicine. Regulatory procedures in the country are not as stringent as those in developed nations of the world. The companies in this market thus use the umbilical cord for stem cell research, as the cords are easily available and are non-controversial for deriving stem cells. Stems cells are considered to be effective in treating several blood-related conditions, owing to their pluripotent nature and are thus used to meet the increasing medical demands of patients. The advancements in stem cell therapy would thereby aid the growth of the 3D cell culture market in India.
The biotechnology firm Synthecon, Incorporated is specialized in designing and manufacturing 3D cell culture systems. The company witnessed a boost in its revenues after NASA-funded researchers purchased the rotary cell culture system (RCCS) it developed. Synthecon utilizes RCCS to develop 3D cell culture models. This technology is based on a patent that NASA developed for a rotating wall vessel RWV bioreactor. In 1995, the company established its distribution channels in the Asia-Pacific and expanded rapidly in the region thereupon.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
Market by Type, End-user, and ..
VIEW REPORT1. ASIA-PACIFIC
3D CELL CULTURE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. ECONOMIC
TECHNOLOGICAL, AND POLITICAL & LEGAL OUTLOOK
2.4. REGULATORY
OUTLOOK
2.5. KEY
INSIGHT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. MARKET
DRIVERS
2.7.1. GROWING
CANCER PREVALENCE
2.7.2. HIGH
DEMAND FOR ORGAN TRANSPLANTATION
2.7.3. PROMISING
DEVELOPMENTS USING REGENERATIVE MEDICINE
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF SKILLED PROFESSIONALS
2.8.2. INCOMPATIBILITIES
OF THE PREFERRED ANALYTICAL TECHNOLOGIES WITH 3D CELL CULTURE
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
USAGE OF 3D CELL CULTURE IN ORGAN TRANSPLANTATION AND DRUG SCREENING
2.9.2. TECHNOLOGICAL
ADVANCEMENT
2.10.
MARKET CHALLENGES
2.10.1.
LACK OF AVAILABILITY OF DATA
FOR RESEARCH ON 3D CELL CULTURE
2.10.2.
CHALLENGES ASSOCIATED WITH 3D
CELL CULTURE IN PERFORMING EXPERIMENTS
3. 3D
CELL CULTURE MARKET OUTLOOK – BY TECHNOLOGY
3.1. SCAFFOLD-BASED
3.1.1. HYDROGELS
3.1.2. POLYMERIC
SCAFFOLDS
3.1.3. MICROPATTERNED
SURFACE MICROPLATES
3.2. SCAFFOLD-FREE
3.2.1. HANGING
DROP MICROPLATES
3.2.2. SPHEROID
MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
3.2.3. MICROFLUIDIC
3D CELL CULTURE
3.2.4. MAGNETIC
LEVITATIONS & 3D BIOPRINTING
3.3. 3D
BIOREACTORS
4. 3D
CELL CULTURE MARKET OUTLOOK – BY APPLICATION
4.1. CANCER
4.2. TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY
4.3. DRUG
DEVELOPMENT
4.4. STEM
CELL RESEARCH
4.5. OTHER
APPLICATIONS
5. 3D
CELL CULTURE MARKET OUTLOOK – BY COMPONENT
5.1. MEDIA
5.2. REAGENTS
AND CONSUMABLES
6. 3D
CELL CULTURE MARKET OUTLOOK – BY END-USER
6.1. BIOTECHNOLOGY
AND PHARMACEUTICAL ORGANIZATIONS
6.2. RESEARCH
LABORATORIES AND INSTITUTES
6.3. HOSPITALS
AND DIAGNOSTIC CENTERS
6.4. OTHER
END-USERS
7. 3D
CELL CULTURE MARKET – REGIONAL OUTLOOK
7.1. ASIA-PACIFIC
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. JAPAN
7.1.1.2. CHINA
7.1.1.3. INDIA
7.1.1.4. AUSTRALIA
& NEW ZEALAND
7.1.1.5. SOUTH
KOREA
7.1.1.6. ASEAN
COUNTRIES
7.1.1.7. REST
OF ASIA-PACIFIC
8. COMPANY
PROFILES
8.1. BECTON
DICKINSON AND COMPANY
8.2. TECAN
GROUP LTD.
8.3. PROMOCELL
GMBH
8.4. CORNING
INC.
8.5. NANO3D
BIOSCIENCES, INC.
8.6. 3D
BIOTEK, LLC
8.7. MERCK
KGAA
8.8. EMULATE
8.9. THERMO
FISHER SCIENTIFIC, INC.
8.10.
GE HEALTHCARE
8.11.
INSPHERO
8.12.
LONZA GROUP AG
8.13.
VWR CORPORATION
8.14.
SYNTHECON, INCORPORATED
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
TABLE 2 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 3 ASIA-PACIFIC SCAFFOLD-BASED MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC SCAFFOLD-FREE MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 5 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 6 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
COMPONENT 2019-2027 ($ MILLION)
TABLE 7 USAGE OF MEDIA IN DIFFERENT STAGES OF
ORGANOIDS FORMATION
TABLE 8 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
END-USER 2019-2027 ($ MILLION)
TABLE 9 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 ASIA-PACIFIC 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE 2 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
SCAFFOLD-BASED 2019-2027 ($ MILLION)
FIGURE 3 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
HYDROGELS 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
POLYMERIC SCAFFOLDS 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
MICROPATTERNED SURFACE MICROPLATES 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
SCAFFOLD-FREE 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
HANGING DROP MICROPLATES 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING 2019-2027 ($
MILLION)
FIGURE 9 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
MICROFLUIDIC 3D CELL CULTURE 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
MAGNETIC LEVITATIONS & 3D BIOPRINTING 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC 3D CELL CULTURE MARKET BY 3D
BIOREACTORS 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC 3D CELL CULTURE MARKET BY CANCER
2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC 3D CELL CULTURE MARKET BY TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC 3D CELL CULTURE MARKET BY DRUG
DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC 3D CELL CULTURE MARKET BY STEM
CELL RESEARCH 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC 3D CELL CULTURE MARKET BY OTHER
APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC 3D CELL CULTURE MARKET BY MEDIA
2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC 3D CELL CULTURE MARKET BY REAGENTS
AND CONSUMABLES 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
RESEARCH LABORATORIES AND INSTITUTES 2019-2027 ($ MILLION)
FIGURE 21 ASIA-PACIFIC 3D CELL CULTURE MARKET BY
HOSPITALS AND DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 22 ASIA-PACIFIC 3D CELL CULTURE MARKET BY OTHER
END-USERS 2019-2027 ($ MILLION)
FIGURE 23 JAPAN 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 24 CHINA 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 25 INDIA 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 26 AUSTRALIA 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 27 SOUTH KOREA 3D CELL CULTURE MARKET 2019-2027
($ MILLION)
FIGURE 28 ASEAN COUNTRIES 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE 29 REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)